Search results
GAMMA Investing LLC Acquires Shares of 238 CrowdStrike Holdings, Inc. (NASDAQ:CRWD)
ETF DAILY NEWS· 3 days agoGAMMA Investing LLC acquired a new stake in CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) during the fourth quarter, Holdings Channel.com reports. The firm acquired 238 shares of the ...
Marriott admits it wasn't using encryption before major 2018 hack
TechRadar· 4 days agoFor five years, the Marriott hotel chain claimed that it had been using secure encryption when it...
PGGM Investments Takes $435,000 Position in CrowdStrike Holdings, Inc. (NASDAQ:CRWD)
ETF DAILY NEWS· 5 days agoPGGM Investments bought a new stake in CrowdStrike Holdings, Inc. (NASDAQ:CRWD – Free Report) during the fourth quarter, according to its most recent disclosure with the Securities and Exchange ...
Veru to Present at the GLP-1 Based Therapeutics Summit
Morningstar· 3 days ago...controlled, randomized, dose-finding clinical trial was designed to evaluate the safety and efficacy of enobosarm 3mg, enobosarm 6mg, or placebo as a treatment to preserve muscle and augment fat loss in approximately 90 patients with sarcopenic obesity or overweight elderly (>60 years of age)...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 3 days agoESET, a global leader in digital security, is pleased to announce the establishment of its first local data centre in Canada, marking a significant milestone in its commitment ...
Kaseya Introduces Revolutionary New Offering, Kaseya 365, Changing the Economics of the MSP Industry...
WFRV 5 Green Bay· 5 days agoKaseya, the leading global provider of IT management and cybersecurity software for managed service providers (MSPs) and small to midsize businesses (SMBs), announced today the launch of Kaseya ...
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
Morningstar· 4 days agoVeru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
Veru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for...
Morningstar· 5 days agoVeru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, oncology, and viral induced ...
A Web of Surveillance - Amnesty International Security Lab
Amnesty International· 3 days agoA web of surveillance research reveals evidence of extensive sales and use of spyware and other...
Stock Market Crash Alert 3 Must-Buy AI Stocks When Prices Plunge
InvestorPlace· 3 days agoThis fell short of the expected 2.4% growth rate leading to a brief period of downturn in the stock...